Cargando…

Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle

BACKGROUND: Skeletal muscle wasting is often associated with insulin resistance. A major regulator of muscle mass is the transforming growth factor β (TGF‐β) superfamily, including activin A, which causes atrophy. TGF‐β superfamily ligands also negatively regulate insulin‐sensitive proteins, but whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiuqing, Møller, Lisbeth Liliendal Valbjørn, De Groote, Estelle, Bojsen‐Møller, Kirstine Nyvold, Davey, Jonathan, Henríquez‐Olguin, Carlos, Li, Zhencheng, Knudsen, Jonas Roland, Jensen, Thomas Elbenhardt, Madsbad, Sten, Gregorevic, Paul, Richter, Erik Arne, Sylow, Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663972/ https://www.ncbi.nlm.nih.gov/pubmed/31402604 http://dx.doi.org/10.1002/jcsm.12474

Ejemplares similares

Rho GTPases—Emerging Regulators of Glucose Homeostasis and Metabolic Health
por: Møller, Lisbeth Liliendal Valbjørn, et al.
Publicado: (2019)

Measurement of skeletal muscle glucose uptake in mice in response to acute treadmill running
por: Møller, Lisbeth Liliendal Valbjørn, et al.
Publicado: (2022)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis—Dysregulation by the Liver
por: London, Amalie, et al.
Publicado: (2021)

NOX2 deficiency exacerbates diet-induced obesity and impairs molecular training adaptations in skeletal muscle
por: Henriquez-Olguin, Carlos, et al.
Publicado: (2023)

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss()
por: Holst, Jens Juul, et al.
Publicado: (2018)

Cytosolic ROS production by NADPH oxidase 2 regulates muscle glucose uptake during exercise
por: Henríquez-Olguin, Carlos, et al.
Publicado: (2019)

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2019)

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
por: Winbanks, Catherine E., et al.
Publicado: (2012)

Periodized low protein-high carbohydrate diet confers potent, but transient, metabolic improvements
por: Li, Zhencheng, et al.
Publicado: (2018)

Housing temperature influences exercise training adaptations in mice
por: Raun, Steffen H., et al.
Publicado: (2020)

The p21‐activated kinase 2 (PAK2), but not PAK1, regulates contraction‐stimulated skeletal muscle glucose transport
por: Møller, Lisbeth L. V., et al.
Publicado: (2020)

Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass
por: Nielsen, Signe, et al.
Publicado: (2017)

Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
por: Hedbäck, Nora, et al.
Publicado: (2022)

The Gut Microbiome on a Periodized Low-Protein Diet Is Associated With Improved Metabolic Health
por: Li, Zhencheng, et al.
Publicado: (2019)

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2013)

Adenosine monophosphate‐activated protein kinase is elevated in human cachectic muscle and prevents cancer‐induced metabolic dysfunction in mice
por: Raun, Steffen H., et al.
Publicado: (2023)

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake
por: Bojsen-Møller, Kirstine Nyvold, et al.
Publicado: (2023)

Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction
por: Tanaka, Komei, et al.
Publicado: (2016)

Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Jonsson, Isabella, et al.
Publicado: (2021)

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2022)

Microtubule-mediated GLUT4 trafficking is disrupted in insulin-resistant skeletal muscle
por: Knudsen, Jonas R, et al.
Publicado: (2023)

Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
por: Sepulveda, Patricio V., et al.
Publicado: (2015)

Bone Geometry Is Altered by Follistatin‐Induced Muscle Growth in Young Adult Male Mice
por: Chan, Audrey S M, et al.
Publicado: (2021)

Obesity and Low-Grade Inflammation Increase Plasma Follistatin-Like 3 in Humans
por: Brandt, Claus, et al.
Publicado: (2014)

The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport
por: Knudsen, Jonas R., et al.
Publicado: (2020)

Follistatin and the Breast Implant Capsule
por: Frenkiel, Brett A., et al.
Publicado: (2017)

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota
por: Palleja, Albert, et al.
Publicado: (2016)

Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease
por: Pearsall, R. S., et al.
Publicado: (2019)

Low‐ and high‐protein diets do not alter ex vivo insulin action in skeletal muscle
por: Li, Zhencheng, et al.
Publicado: (2018)

Inactivating hepatic follistatin alleviates hyperglycemia
por: Tao, Rongya, et al.
Publicado: (2018)

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine
por: Modvig, Ida M., et al.
Publicado: (2020)

Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
por: Iskenderian, Andrea, et al.
Publicado: (2018)

Serum Activin A and Follistatin Levels in Gestational Diabetes and the Association of the Activin A-Follistatin System with Anthropometric Parameters in Offspring
por: Näf, Silvia, et al.
Publicado: (2014)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Adaptations to high-intensity interval training in skeletal muscle require NADPH oxidase 2
por: Henríquez-Olguín, Carlos, et al.
Publicado: (2019)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells
por: Shi, Feng-Tao, et al.
Publicado: (2011)

SAT032 Circulating Neprilysin Activity Is Increased In Type 2 Diabetes And Fatty Liver Disease, And Reduces Following Bariatric Surgery And Liraglutide Therapy
por: Sampson Kjeldsen, Sasha Alexandra, et al.
Publicado: (2023)

Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training
por: Negaresh, Raoof, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nl28tchd4rmes2j20qmtlim1i2